capsaicin 0.000375 MG/MG / lidocaine 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment
- RxCUI
- 1876751
- RxNorm name
- capsaicin 0.000375 MG/MG / lidocaine 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment
- Display name
- Capsaicin/Lidocaine/Menthol/Methyl salicylate (Topical)
- Full name
- capsaicin 0.000375 MG/MG / lidocaine 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment
- Term type
- SCD
- Status
- Active
- Strength
- 0.0375-4-10-20%
- Dose form
- Ointment
- Route
- Topical
- Updated
- 2026-10-27 19:31:25
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 052017
- Active start
- 052017
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| capsaicin | 0.000375 MG / 1 MG | capsaicin | capsaicin |
| methyl salicylate | 0.2 MG / 1 MG | methyl salicylate | methyl salicylate |
| lidocaine hydrochloride | 0.04 MG / 1 MG | lidocaine | lidocaine |
| menthol | 0.1 MG / 1 MG | menthol | menthol |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Topical Ointment | 316985 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| capsaicin | 1992 |
| methyl salicylate | 29787 |
| lidocaine | 6387 |
| menthol | 6750 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | capsaicin 0.000375 MG/MG / lidocaine 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Name | capsaicin 0.000375 MG/MG / lidocaine 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment | 1 | NAMES |
| RxNorm Synonym | capsaicin 0.0375 % / lidocaine 4 % / menthol 10 % / methyl salicylate 20 % Topical Ointment | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| RxCUI | 1876751 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8e822dc1-f770-0c86-e053-2a95a90afff5 | capsaicin 0.0375 % / lidocaine 4 % / menthol 10 % / methyl salicylate 20 % Topical Ointment [PSN] · capsaicin 0.000375 MG/MG / lidocaine 0.04 MG/MG / menthol 0.1 MG/MG / methyl salicylate 0.2 MG/MG Topical Ointment [SCD] · capsaicin 0.0375 % / lidocaine 4 % / menthol 10 % / methyl salicylate 20 % Topical Ointment [SY] | 3 | 2 | TRANSDERM-IQ | 20190911 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| f21442fa-e792-464a-baf1-5016ccc64d8a | Transderm-iQ | Pocono Coated Products, LLC | 20190920 |
| 8e822dc1-f770-0c86-e053-2a95a90afff5 | TRANSDERM-IQ | Direct_Rx | 20190911 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N01BB | Amides | ATC1-4 | lidocaine | |
| ATC | S02DA | Analgesics and anesthetics | ATC1-4 | lidocaine | |
| ATC | D04AB | Anesthetics for topical use | ATC1-4 | lidocaine | |
| ATC | R02AD | Anesthetics, local | ATC1-4 | lidocaine | |
| ATC | C01BB | Antiarrhythmics, class Ib | ATC1-4 | lidocaine | |
| ATC | M02AB | Capsaicin and similar agents | ATC1-4 | capsaicin | |
| ATC | C05AD | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | S01HA | Local anesthetics | ATC1-4 | lidocaine | |
| ATC | N01BX | Other local anesthetics | ATC1-4 | capsaicin | |
| FDASPL | N0000175682 | Amide Local Anesthetic | EPC | has_epc | lidocaine |
| FDASPL | N0000175426 | Antiarrhythmic | EPC | has_epc | lidocaine |
| FDASPL | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
| MEDRT | D002211 | Capsaicin | CHEM | has_ingredient | capsaicin |
| MEDRT | D008012 | Lidocaine | CHEM | has_ingredient | lidocaine |
| MEDRT | D008610 | Menthol | CHEM | has_ingredient | menthol |
| MEDRT | D012459 | Salicylates | CHEM | has_ingredient | methyl salicylate |
| MEDRT | D059787 | Acute Pain | DISEASE | may_treat | methyl salicylate |
| MEDRT | D000219 | Adams-Stokes Syndrome | DISEASE | ci_with | lidocaine |
| MEDRT | D001168 | Arthritis | DISEASE | may_treat | methyl salicylate |
| MEDRT | D001416 | Back Pain | DISEASE | may_treat | methyl salicylate |
| MEDRT | D002056 | Burns | DISEASE | may_treat | lidocaine |
| MEDRT | D003288 | Contusions | DISEASE | may_treat | methyl salicylate |
| MEDRT | D003929 | Diabetic Neuropathies | DISEASE | may_treat | capsaicin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | capsaicin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | menthol |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | methyl salicylate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D064420 | Drug-Related Side Effects and Adverse Reactions | DISEASE | may_treat | lidocaine |
| MEDRT | D004935 | Esophageal Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D006562 | Herpes Zoster | DISEASE | may_treat | capsaicin |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | lidocaine |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | methyl salicylate |
| MEDRT | D009059 | Mouth Diseases | DISEASE | may_treat | lidocaine |
| MEDRT | D009120 | Muscle Cramp | DISEASE | may_treat | methyl salicylate |
| MEDRT | D009437 | Neuralgia | DISEASE | may_treat | capsaicin |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | lidocaine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | menthol |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | capsaicin |
| MEDRT | D012871 | Skin Diseases | DISEASE | may_treat | menthol |
| MEDRT | D013180 | Sprains and Strains | DISEASE | may_treat | methyl salicylate |
| MEDRT | D013614 | Tachycardia, Paroxysmal | DISEASE | may_treat | lidocaine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | may_treat | lidocaine |
| MEDRT | D014693 | Ventricular Fibrillation | DISEASE | may_treat | lidocaine |
| MEDRT | D018879 | Ventricular Premature Complexes | DISEASE | may_treat | lidocaine |
| MEDRT | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | menthol |
| MEDRT | N0000000160 | Cyclooxygenase Inhibitors | MOA | has_moa | methyl salicylate |
| MEDRT | N0000000105 | Neurotransmitter Transporter Interactions | MOA | has_moa | capsaicin |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | methyl salicylate |
| MEDRT | N0000000180 | Sodium Channel Interactions | MOA | has_moa | lidocaine |
| MEDRT | N0000008330 | Cardiac Rhythm Alteration | PE | has_pe | lidocaine |
| MEDRT | N0000008472 | Decreased Cardiac Muscle Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | methyl salicylate |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | lidocaine |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | capsaicin |
| MEDRT | N0000008889 | Decreased Sensory-Somatic Nervous System Organized Electrical Activity | PE | has_pe | menthol |
| MEDRT | N0000009006 | Decreased Thromboxane Production | PE | has_pe | methyl salicylate |
| MEDRT | N0000175976 | Local Anesthesia | PE | has_pe | lidocaine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.000375 MG/MG / 0.04 MG/MG / 0.1 MG/MG / 0.2 MG/MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| NAMES | Prescribable Synonym | capsaicin 0.0375 % / lidocaine 4 % / menthol 10 % / methyl salicylate 20 % Topical Ointment |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |